AMLN Related Momentum Movers
-
Amylin (AMLN) Shares Dip Ahead of Close
-
Amylin (AMLN) Shares Rally Into Close as WSJ Says Bristol (BMY) Still Looking at Co.
-
Analysts Expecting Higher Bids for Amylin (AMLN)
-
Amylin (AMLN) Shares Surge 50+% Amid Rumor Co. Rejected $3.5B Bid from Bristol (BMY)
-
Amylin (AMLN) Shares Up 7.5% Amid Byetta/Bydureon Data; CEO Says 'Very Confident' in Diabetes Treatments
-
Amylin (AMLN) Shares Jump 14% Amid BYDUREON Recommendation for Approval in Europe
-
Amylin (AMLN), Takeda Suspend Obesity Treatment Trial; Amylin Lower Pre-Market
-
Amylin Pharmaceuticals (AMLN) Cut In Half After FDA CRL on BYDUREON
-
Amylin (AMLN) Jumps On Taspo Delay
-
Amylin (AMLN) and Takeda Enter Development Agreement for Obesity Treatments
Back to AMLN Stock Lookup
